LENZ Therapeutics

LENZ • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31
Revenue $0
Gross Profit
EBITDA -16,083
EBIT -16,088
Net Income -16,648
Net Change In Cash 0
Free Cash Flow -23,937
Cash 200,357
Basic Shares 4,717

Annual Financials

Values in thousands 2022-09-30 2021-09-30
Revenue $15,000 $0
Gross Profit 6,654 -734
EBITDA -97,293 -59,709
EBIT -105,639 -60,443
Net Income -101,052 -70,760
Net Change In Cash 15,000 0
Free Cash Flow -94,574 -58,592
Cash 47,730 376,976
Basic Shares 23,517 24,861

Earnings Calls

Quarter EPS
2023-12-31 -$0.40
2023-09-30 -$2.73
2023-06-30 -$6.79
2023-03-31 -$3.01